International Journal of Biomedicine. 2023;13(1):41-46.
Originally published March 3, 2023
Background: Education and treatment programs can help children and adolescents with type 1 diabetes (T1D), and their parents, to independently carry out the necessary measures to achieve the treatment goals. In this regard, it seems extremely relevant to develop and evaluate the effectiveness of a training-modified program, considering national characteristics for children and adolescents with T1D who are devoted to using insulin pumps for insulin administration. The purpose of this work was to evaluate the effectiveness of a modified training program in achieving target levels of glycemia in children and adolescents with T1D on insulin pump therapy in Almaty.
Methods and Results: Our study included 125 children and adolescents with T1D who were divided into 2 groups. The main group (MG), with a modified educational program, consisted of 68 children and adolescents with T1D who studied quarterly at the "School of T1D." The comparison group (CG) consisted of 57 children and adolescents with T1D who were on outpatient and inpatient treatment in different clinics and were trained in the "School of T1D" by the traditional method. All surveyed children and adolescents took a training course 2-3 times a year (each session 5 days long) from 2018 to 2021.
The patients of MG and CG were divided into 2 subgroups depending on the method of assessing glycemia: self-monitoring blood glucose (SMBG) using an individual glucometer and FreeStyle Libre Glucose Sensor (FSLGS) for continuous glucose monitoring (CGM). The modified program included the installation of Flash monitoring and a strategy to increase time in the target range, as well as calculating the insulin bolus dose in bread units, calculated in national dishes, then monitoring treatment correction.
After a year of training, the frequency of achieving target levels of HbA1c (≤7.0%) increased to 60.5% compared to 30.6% at the initial stage in the main subgroup with SMBG and 66.4% versus 28.7% in the main subgroup with the FSLGS for CGM; it was significant in both cases (P=0.01). In the comparison subgroups, achieving target levels of HbA1c was less pronounced and not significant (46.2% compared to 29.5% at the initial stage in the subgroup with SMBG and 51.1% compared to 29.1% at the initial stage in the subgroup with the FSLGS for CGM, P>0.05 in both cases).
Conclusion: CGM and modified learning significantly contribute to the management of T1D, are associated with lower HbA1c levels and longer stay in the time-in-range, and increase the commitment of patients and their parents to the self-control of glucose.
- Ibragimova LI, Philippov YI, Mayorov AY. Insulin pump therapy in type 1 diabetes mellitus: education effectiveness and quality of life. Diabetes mellitus, 2012, 15(1), 35‐40. doi: 10.14341 / 2072-0351-5977.
- Mayorov AYu, Surkova EV, Motovilin OG, Mel'nikova OG, Shishkova YuA. [Education of diabetic patients: synthesis of evidence-based medicine and psychological approach]. Diabetes mellitus. 2011;14(1):46-52. [Article in Russian].
- DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K, Maahs DM. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018 Oct;19 Suppl 27:105-114. doi: 10.1111/pedi.12737.
- Almaty city branch "Republican Center for Electronic Health" of the Ministry of Health of the Republic of Kazakhstan. http://riac-almaty.kz/index.php/ru/
- Galstyan GR, Maiorov AY, Dvoinishnikova ОМ, Bessmertnaya YG, Milenkaya TM, Suntsov YI, Antsiferov MВ, Dedov II. [Long-term results of therapeutic education of patients with type 1 diabetes mellitus]. Probl Endokrinol (Mosk). 2005 Jun 15;51(3):50-55. doi: 10.14341/probl200551350-55. [Article in Russian].
- Mensing C, Boucher J, Cypress M, Weinger K, Mulcahy K, Barta P, Hosey G, Kopher W, Lasichak A, Lamb B, Mangan M, Norman J, Tanja J, Yauk L, Wisdom K, Adams C. National standards for diabetes self-management education. Diabetes Care. 2007 Jan;30 Suppl 1:S96-S103. doi: 10.2337/dc07-S096.
- American Diabetes Association. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S77-S88. doi: 10.2337/dc20-S007. Erratum in: Diabetes Care. 2020 Aug;43(8):1981.
- American Diabetes Association. Addendum. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020;43(Suppl. 1):S77-S88. Diabetes Care. 2020 Aug;43(8):1981. doi: 10.2337/dc20-ad08c. Epub 2020 Jun 5. Erratum for: Diabetes Care. 2020 Jan;43(Suppl 1):S77-S88.
- Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600.
- Gehr B, Holder M, Kulzer B, Lange K, Liebl A, Sahm C, et al.; SPECTRUM Group. SPECTRUM. J Diabetes Sci Technol. 2017 Mar;11(2):284-289. doi: 10.1177/1932296816661735.
- Schlüter S, Freckmann G, Heinemann L, Wintergerst P, Lange K. Evaluation of the SPECTRUM training programme for real-time continuous glucose monitoring: A real-world multicentre prospective study in 120 adults with type 1 diabetes. Diabet Med. 2021 Feb;38(2):e14467. doi: 10.1111/dme.14467.
- Pemberton JS, Kershaw M, Dias R, Idkowiak J, Mohamed Z, Saraff V, Barrett TG, Krone R, Uday S. DYNAMIC: Dynamic glucose management strategies delivered through a structured education program improves time in range in a socioeconomically deprived cohort of children and young people with type 1 diabetes with a history of hypoglycemia. Pediatr Diabetes. 2021 Mar;22(2):249-260. doi: 10.1111/pedi.13155. Epub 2021 Jan 15. Erratum in: Pediatr Diabetes. 2022 Feb;23(1):166-168.
- Phelan H, Lange K, Cengiz E, Gallego P, Majaliwa E, Pelicand J, Smart C, Hofer SE. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents. Pediatr Diabetes. 2018 Oct;19 Suppl 27:75-83. doi: 10.1111/pedi.12762.
- Hermanns N, Ehrmann D, Schipfer M, Kröger J, Haak T, Kulzer B. The impact of a structured education and treatment programme (FLASH) for people with diabetes using a flash sensor-based glucose monitoring system: Results of a randomized controlled trial. Diabetes Res Clin Pract. 2019 Apr;150:111-121. doi: 10.1016/j.diabres.2019.03.003.
- NICE: National Institute for Clinical Excellence. NICE Technology Appraisal Guidance No 60. Guidance on the use of patient-education models for diabetes. Published: 26 April 2003 Last updated: 01 August 2015. Available from: https://www.nice.org.uk/guidance/ng17
- Plank J, Köhler G, Rakovac I, Semlitsch BM, Horvath K, Bock G, Kraly B, Pieber TR. Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up. Diabetologia. 2004 Aug;47(8):1370-5. doi: 10.1007/s00125-004-1456-x.
- Ismailov S, Rakhimova G, Tashmanova A, Abdurazakova Z. [Evaluation of Clinical and Metabolic Parameters of Efficiency of Long-term Training and Achievement of Target Levels of Type 1 Diabetes Mellitus Therapy in Children and Adolescents]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine). 2014;(6.62):19–23. doi: 10.22141/2224-0722.214.171.1244.76930. [Article in Russian].
- Rakhimova GN, Ismailov SI, Alimova NU, Tashmanova AB, Alieva AV. Type 1 diabetes mellitus in children and adolescents. Methodical manuals for children, adolescents, and their parents. Tashkent, 2012. [In Russian].
- Rakhimova G.N, Ismailov SI, Alimova NU, Akbarov AZ, Tashmanova AB, Alieva AV. National standards of care for children and adolescents with type 1 diabetes. Methodical recommendation. Tashkent, 2013. [In Russian].
- Tashmanova A, Ismailov S, Rakhimova G, Abdurazakova Z. [Evaluating the Efficacy of New Structured Program for Teaching Patients with Diabetes Mellitus Type 1 in the Republic of Uzbekistan]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine). 2014.(1.57):46–50. doi:10.22141/2224-07126.96.36.1994.76401. [Article in Russian].
Received October 12, 2022.
Accepted February 6, 2023.
©2023 International Medical Research and Development Corporation.